Patents Assigned to Bioceuticals, Inc.
  • Publication number: 20090042822
    Abstract: A therapeutic method is provided comprising treating a mammal subject to hypoxia with an amount of 2(R,S)-D-ribo-(1?,2?,3?,4?-tetrahydroxybutyl)thiazolidine-4(R)-carboxylic acid (RibCys) or a pharmaceutically acceptable salt thereof effective to both maintain, restore or increase both the ATP levels and the glutathione (GSH) levels in said tissue.
    Type: Application
    Filed: July 30, 2008
    Publication date: February 12, 2009
    Applicant: Bioceuticals, Inc.
    Inventor: Herbert T. Nagasawa